Cargando…

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis

Detalles Bibliográficos
Autores principales: Clark, Marcus R, Chang, Anthony, Ko, Kichul, Henry Dunand, Carole J, Henderson, Scott, Brandt, Dan, Kaverina, Natalya, Liarski, Vladimir, Wilson, Patrick C, Kinloch, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179523/
http://dx.doi.org/10.1186/ar4634
_version_ 1782337102377123840
author Clark, Marcus R
Chang, Anthony
Ko, Kichul
Henry Dunand, Carole J
Henderson, Scott
Brandt, Dan
Kaverina, Natalya
Liarski, Vladimir
Wilson, Patrick C
Kinloch, Andrew J
author_facet Clark, Marcus R
Chang, Anthony
Ko, Kichul
Henry Dunand, Carole J
Henderson, Scott
Brandt, Dan
Kaverina, Natalya
Liarski, Vladimir
Wilson, Patrick C
Kinloch, Andrew J
author_sort Clark, Marcus R
collection PubMed
description
format Online
Article
Text
id pubmed-4179523
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41795232014-10-14 Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis Clark, Marcus R Chang, Anthony Ko, Kichul Henry Dunand, Carole J Henderson, Scott Brandt, Dan Kaverina, Natalya Liarski, Vladimir Wilson, Patrick C Kinloch, Andrew J Arthritis Res Ther Meeting Abstract BioMed Central 2014 2014-09-18 /pmc/articles/PMC4179523/ http://dx.doi.org/10.1186/ar4634 Text en Copyright © 2014 Clark et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Clark, Marcus R
Chang, Anthony
Ko, Kichul
Henry Dunand, Carole J
Henderson, Scott
Brandt, Dan
Kaverina, Natalya
Liarski, Vladimir
Wilson, Patrick C
Kinloch, Andrew J
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title_full Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title_fullStr Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title_full_unstemmed Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title_short Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
title_sort vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179523/
http://dx.doi.org/10.1186/ar4634
work_keys_str_mv AT clarkmarcusr vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT changanthony vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT kokichul vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT henrydunandcarolej vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT hendersonscott vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT brandtdan vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT kaverinanatalya vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT liarskivladimir vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT wilsonpatrickc vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis
AT kinlochandrewj vimentinisadominanttargetofinsituhumoralimmunityinhumanlupustubulointerstitialnephritis